Description
An inhibitor of cyclin-dependent kinases (IC50s = 0.15, 0.08, 0.06, 0.12, and 0.11 µM for Cdk1/cyclin B, Cdk2/cyclin A, Cdk2/cyclin E, Cdk5/p25, and Cdk9/cyclin T, respectively); inhibits CK1δ/ε and DYRK1A (IC50s = 0.61 and 0.9 µM, respectively); reduces cell viability in human neuroblastoma cell lines, including SH-SY5Y, SK-N-AS, SK-N-BE, and IMR32 cells (IC50s = 0.43, 1.46, 0.13, and 0.14 µM, respectively)
Formal name: (2S)-2-[[9-(1-methylethyl)-6-[[[4-(2-pyridinyl)phenyl]methyl]amino]-9H-purin-2-yl]amino]-1-butanol
Synonyms:
Molecular weight: 431.5
CAS: 1084893-56-0
Purity: ≥98%
Formulation: A solid